OBJECTIVE: Mood instability is common in the general population. Mood instability is a precursor to mental illness and associated with a range of negative health outcomes. Sleep disturbance appears to be closely linked with mood instability. This study assesses the association between mood instability and sleep disturbance and the link with suicidal ideation and behaviour in a general population sample in England. METHOD: The Adult Psychiatric Morbidity Survey, 2007 collected detailed information about mental health symptoms and correlates in a representative sample of adult household residents living in England ( n = 7303). Mood instability was assessed using the Structured Clinical Interview for DSM-IV Axis-II. Sleep problems were defined as sleeping more than usual or less than usual during the past month. Other dependent variables included medication use and suicidal ideation and behaviour (response rate 57%). Generalized linear modelling was used to estimate the prevalence of mood instability and sleep problems. Logistic regression was used to estimate odds ratios. All estimates were weighted. RESULTS: The prevalence of mood instability was 14.7% (95% confidence interval [13.6%, 15.7%]). Sleep problems occurred in 69.8% (95% confidence interval: [66.6%, 73.1%]) of those with mood instability versus 37.6% (95% confidence interval: [36.2%, 39.1%]) of those without mood instability. The use of sedating and non-sedating medications did not influence the association. Sleep problems were significantly associated with suicidal ideation and behaviour even after adjusting for mood instability. CONCLUSION: Sleep problems are highly prevalent in the general population, particularly among those with mood instability. Sleep problems are strongly associated with suicidal ideation and behaviour. Treatments that target risk and maintenance factors that transcend diagnostic boundaries, such as therapies that target sleep disturbance, may be particularly valuable for preventing and addressing complications related to mood instability such as suicide.
OBJECTIVE: Mood instability is common in the general population. Mood instability is a precursor to mental illness and associated with a range of negative health outcomes. Sleep disturbance appears to be closely linked with mood instability. This study assesses the association between mood instability and sleep disturbance and the link with suicidal ideation and behaviour in a general population sample in England. METHOD: The Adult Psychiatric Morbidity Survey, 2007 collected detailed information about mental health symptoms and correlates in a representative sample of adult household residents living in England ( n = 7303). Mood instability was assessed using the Structured Clinical Interview for DSM-IV Axis-II. Sleep problems were defined as sleeping more than usual or less than usual during the past month. Other dependent variables included medication use and suicidal ideation and behaviour (response rate 57%). Generalized linear modelling was used to estimate the prevalence of mood instability and sleep problems. Logistic regression was used to estimate odds ratios. All estimates were weighted. RESULTS: The prevalence of mood instability was 14.7% (95% confidence interval [13.6%, 15.7%]). Sleep problems occurred in 69.8% (95% confidence interval: [66.6%, 73.1%]) of those with mood instability versus 37.6% (95% confidence interval: [36.2%, 39.1%]) of those without mood instability. The use of sedating and non-sedating medications did not influence the association. Sleep problems were significantly associated with suicidal ideation and behaviour even after adjusting for mood instability. CONCLUSION: Sleep problems are highly prevalent in the general population, particularly among those with mood instability. Sleep problems are strongly associated with suicidal ideation and behaviour. Treatments that target risk and maintenance factors that transcend diagnostic boundaries, such as therapies that target sleep disturbance, may be particularly valuable for preventing and addressing complications related to mood instability such as suicide.
Authors: Louisa G Sylvia; Jamie M Dupuy; Michael J Ostacher; Colleen M Cowperthwait; Aleena C Hay; Gary S Sachs; Andrew A Nierenberg; Roy H Perlis Journal: J Psychopharmacol Date: 2011-09-29 Impact factor: 4.153
Authors: Daniel J Gottlieb; Naresh M Punjabi; Ann B Newman; Helaine E Resnick; Susan Redline; Carol M Baldwin; F Javier Nieto Journal: Arch Intern Med Date: 2005-04-25
Authors: Rashmi Patel; Theodore Lloyd; Richard Jackson; Michael Ball; Hitesh Shetty; Matthew Broadbent; John R Geddes; Robert Stewart; Philip McGuire; Matthew Taylor Journal: BMJ Open Date: 2015-05-21 Impact factor: 2.692
Authors: Lauren Z Atkinson; Lucy Colbourne; Alexander Smith; Catherine H Harmer; Anna C Nobre; Jennifer Rendell; Helen Jones; Christopher Hinds; Arne Mould; Elizabeth M Tunbridge; Andrea Cipriani; John R Geddes; Kate E A Saunders; Paul J Harrison Journal: Trials Date: 2019-02-12 Impact factor: 2.279
Authors: Isabella de Araújo Esteves Duarte; Dragan Milenkovic; Tatiana Karla Dos Santos Borges; Artur Jordão de Magalhães Rosa; Christine Morand; Livia de Lacerda de Oliveira; Ana Maria Costa Journal: Nutrients Date: 2020-04-16 Impact factor: 5.717
Authors: O Carr; K E A Saunders; A Tsanas; A C Bilderbeck; N Palmius; J R Geddes; R Foster; G M Goodwin; M De Vos Journal: Sci Rep Date: 2018-01-26 Impact factor: 4.379
Authors: Keltie McDonald; Tanya Smith; Matthew Broadbent; Rashmi Patel; John R Geddes; Kate E A Saunders Journal: Eur Psychiatry Date: 2020-04-27 Impact factor: 5.361